PAX3 and melanoma: Moreover, overexpression of PAX3 (paired box homeotic gene 3) or activation of STAT3 led to vemurafenib, a selective inhibitor of Braf, resistance in melanoma cells, and silencing of PAX3 and STAT3 reduced growth of vemurafenib resistance melanoma cells [21,22].